Form 4: Sera Prognostics CCO Acquires Shares via ESPP

Chief Commercial Officer Dyaarl Lee Anderson Jr. acquired 3,168 shares of Sera Prognostics common stock through the company's Employee Stock Purchase Plan.

Summary

• Dyaarl Lee Anderson Jr., Chief Commercial Officer of Sera Prognostics, Inc., acquired 3,168 shares of Class A Common Stock.
• The transaction occurred on May 29, 2026, at a price of $1.84 per share.
• Following this transaction, the reporting person holds a total of 82,737 shares of Class A Common Stock.
• The acquisition was executed under the company's 2021 Employee Stock Purchase Plan (ESPP).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, planned purchase under an existing employee benefit program.

Positives

• Insider participation in the company's Employee Stock Purchase Plan indicates alignment between management and shareholder interests.

Negatives

• None identified.

Risks

• The investment is subject to general market risks associated with the biotechnology and diagnostics sector.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider acquisitions via ESPPs are standard corporate practice and generally reflect internal confidence in the company's long-term equity value rather than a reaction to specific market catalysts.

Comparison to Industry Standards

• The use of ESPPs is a standard compensation and retention tool across the biotechnology industry.
• The transaction size is consistent with typical executive participation levels in such plans.

Stakeholder Impact

• Minor increase in insider ownership alignment.

Next Steps

• None specified.

Key Dates

Keywords

Sera Prognostics, SERA, Insider Trading, Form 4, ESPP, Biotechnology